Ocular Therapeutix Inc. (OCUL) is priced at $11.27 after the most recent trading session. At the very opening of the session, the stock price was $12.22 and reached a high price of $12.22, prior to closing the session it reached the value of $12.35. The stock touched a low price of $11.21.Recently in News on July 23, 2021, Ocular Therapeutix™ To Present Clinical Data at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced multiple scientific presentations at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting being held July 23-27, 2021 in Las Vegas, NV. You can read further details here
Ocular Therapeutix Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $23.68 on 01/11/21, with the lowest value was $11.21 for the same time period, recorded on 07/26/21.
Ocular Therapeutix Inc. (OCUL) full year performance was 31.97%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ocular Therapeutix Inc. shares are logging -53.62% during the 52-week period from high price, and 57.84% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $7.14 and $24.30.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1498621 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Ocular Therapeutix Inc. (OCUL) recorded performance in the market was -45.56%, having the revenues showcasing -29.96% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 843.78M, as it employees total of 181 workers.
Ocular Therapeutix Inc. (OCUL) in the eye of market guru’s
During the last month, 0 analysts gave the Ocular Therapeutix Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 15.50, with a change in the price was noted -6.30. In a similar fashion, Ocular Therapeutix Inc. posted a movement of -35.86% for the period of last 100 days, recording 1,024,191 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for OCUL is recording 0.58 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.48.
Ocular Therapeutix Inc. (OCUL): Stocks Technical analysis and Trends
Raw Stochastic average of Ocular Therapeutix Inc. in the period of last 50 days is set at 1.43%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.70%. In the last 20 days, the company’s Stochastic %K was 10.41% and its Stochastic %D was recorded 16.63%.
If we look into the earlier routines of Ocular Therapeutix Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -45.56%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -45.90%, alongside a boost of 31.97% for the period of the last 12 months. The shares increased approximately by -7.62% in the 7-day charts and went up by -22.97% in the period of the last 30 days. Common stock shares were lifted by -29.96% during last recorded quarter.